Loading clinical trials...
Loading clinical trials...
A Safety and Efficacy Study of Tavilermide Ophthalmic Solution for the Treatment of Dry Eye Disease
Conditions
Interventions
1% Tavilermide Ophthalmic Solution
Placebo Ophthalmic Solution
Locations
1
United States
MIM-726 Investigational Site
Torrance, California, United States
Start Date
January 1, 2016
Primary Completion Date
February 1, 2017
Completion Date
March 1, 2017
Last Updated
August 16, 2019
NCT03925727
NCT03418259
NCT02688556
NCT02845674
NCT01797822
NCT03408015
Lead Sponsor
Mimetogen Pharmaceuticals USA, Inc.
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions